Vistara Growth is proud to announce the promotion of Chris Angelatos to Director.
Chris leads Vistara’s HealthTech investment efforts, where he has been instrumental in sourcing and executing investments and helping shape the firm’s growing presence in the sector. As healthcare continues to represent a compelling opportunity for innovation and investment, Chris has played a central role in expanding Vistara’s expertise and activity across the space since joining the firm in 2023, building on his prior experience. Most recently, Chris led Vistara’s investments in Tendo and Glooko, where he currently serves as a Board Observer for both companies.
Chris’s promotion to Director recognizes not only his investment acumen, but also his leadership, initiative, and commitment to building for the long term. In his new role, he will continue to play an important part in advancing Vistara’s investment strategy, mentoring other team members, and helping drive strategic initiatives across the firm.
We are proud to celebrate this well-deserved milestone and look forward to Chris’s continued success as a member of Vistara’s leadership team.
Explore Chris’s Work:
Looking for Flexible Growth Capital?
Read our case studies to learn how our growth debt and equity solutions have enabled our founders and helped our portfolio companies.
